Sōlaria Biō

Sōlaria Biō is a U.S.-based life-sciences company, headquartered in Cambridge, Massachusetts, that develops and markets a clinically studied bone-health synbiotic under the brand Bōndia. The company was formerly known as Journa Health and rebranded to Sōlaria Biō; its website now carries the banner "JOURNA HEALTH IS NOW SŌLARIA BIŌ." The company positions itself at the intersection of pharmaceutical rigor and over-the-counter accessibility, describing Bōndia as "the world's first living, plant-sourced synbiotic proven to protect you from the silent epidemic of bone loss." Sōlaria Biō's flagship product, Bōndia, is a prebiotic-plus-probiotic capsule marketed as the "#1 practitioner-recommended synbiotic" that addresses inflammation starting in the gut and protects bone density. The company cites a 12-month, double-blind, randomized, placebo-controlled clinical trial in 286 women, published in Osteoporosis International (2025), in which Bōndia improved bone density outcomes by 85% in women with osteopenia. The product is sold direct-to-consumer through the company's website, with one-month, three-month, and annual subscription options, a 30-day money-back guarantee, and a free starter kit with first shipments. Sōlaria Biō also runs a "For Providers" program and publishes a blog, The Longevity Edit, covering bone health, menopause and midlife, gut and microbiome, and nutrition and lifestyle topics. The company has partnered with DexaFit to offer bone-health packages in the San Francisco Bay Area, including free DEXA scans with a Bōndia subscription, and hosts webinars on hormones, gut health, and bone health. Its content marketing emphasizes the slow timeline of bone loss and the importance of consistent daily support. Sōlaria Biō is a private company; no parent company or ownership details are disclosed in the available evidence.

Sōlaria Biō is a U.S. life-sciences company based in Cambridge, Massachusetts. It was formerly known as Journa Health and rebranded to Sōlaria Biō; the company's website now displays the message "JOURNA HEALTH IS NOW SŌLARIA BIŌ." The company focuses on bone health and the gut microbiome, developing a plant-sourced synbiotic called Bōndia. Bōndia is marketed as the world's first living, plant-sourced synbiotic proven to protect against bone loss. The product's clinical evidence comes from a 12-month, double-blind, randomized, placebo-controlled trial in 286 women, published in Osteoporosis International in 2025, which reported an 85% improvement in bone density outcomes in women with osteopenia. Sōlaria Biō sells Bōndia direct-to-consumer via its website, offering one-month, three-month, and annual subscription plans, and maintains a "For Providers" program for healthcare practitioners. The company also publishes a blog, The Longevity Edit, and has partnered with DexaFit to offer bone-health packages including DEXA scans in the San Francisco Bay Area. As of the available evidence, Sōlaria Biō is a private company; no parent company or ownership details are disclosed.

• Clinical trial results for Bōndia published in Osteoporosis International, showing 85% improvement in bone density outcomes.

• Rebranded from Journa Health to Sōlaria Biō.

• Partnered with DexaFit to offer bone-health packages with DEXA scans in the SF Bay Area.

Pharmaceutical rigor meets OTC accessibility; clinically proven bone-health synbiotic.

• Bōndia Prebiotic + Probiotic capsule

  A plant-sourced synbiotic marketed as the #1 practitioner-recommended synbiotic for bone health, addressing inflammation starting in the gut and protecting bone density.

1. 1Solaria Bio – sōlaria biōsolaria.bio
2. 2Bondia™ Bone Health Synbiotic | Clinically Proven Support – sōlaria biōsolaria.bio
3. 3Sōlaria Biō Blog | Insights on Bone Health, Aging & Wellness – tagged "Company News & Events" – sōlaria biōsolaria.bio
4. 4Solarea Bio (United States)wikidata.org